This month's Journal of Viral Hepatitis reports that decisions regarding HCV treatment should consider the predictive value of the early on-treatment response, not just baseline characteristics.
The most recent issue of Inflammatory Bowel Disease investigates colitis-associated DNA aneuploidy and dysplasia in Crohn's disease and the risk of colorectal cancer.
This month's issue of the Journal of Viral Hepatitis compares 48 weeks with 72 weeks of pegylated interferon and ribavirin for treatment naïve chronic hepatitis C genotype 1 late viral responders.
The latest issue of Gut investigates the accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise.
A study in May's issue of the Inflammatory Bowel Diseases assesses knowledge in adolescents with inflammatory bowel disease using a novel transition tool.
A review in this month's American Journal of Gastroenterology reports that glucocorticosteroids are probably effective in inducing remission in ulcerative colitis.
This month's issue of the Journal of Viral Hepatitis investigates the influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow’s injecting drug user population.
A study in this week's issue of the Journal of the American Medical Association investigates the safety and immunogenicity of intramuscular double and low doses vs standard hepatitis B vaccine in adults with HIV-1.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .